<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">medRxiv</journal-id><journal-id journal-id-type="pmc-domain-id">3854</journal-id><journal-id journal-id-type="pmc-domain">medrxiv</journal-id><journal-id journal-id-type="publisher-id">MEDRXIV</journal-id><journal-title-group><journal-title>medRxiv</journal-title></journal-title-group><publisher><publisher-name>Cold Spring Harbor Laboratory Preprints</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10863005</article-id><article-id pub-id-type="pmcid-ver">PMC10863005.1</article-id><article-id pub-id-type="pmcaid">10863005</article-id><article-id pub-id-type="pmcaiid">10863005</article-id><article-id pub-id-type="pmid">38352545</article-id><article-id pub-id-type="doi">10.1101/2024.01.29.24301962</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>
Benefits of Aeroallergen Testing on Oral Corticosteroid Bursts in Adults with Asthma
</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gleeson</surname><given-names initials="PK">Patrick K.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morales</surname><given-names initials="KH">Knashawn H.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Buckey</surname><given-names initials="TM">Timothy M.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fadugba</surname><given-names initials="OO">Olajumoke O.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Apter</surname><given-names initials="AJ">Andrea J.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Christie</surname><given-names initials="JD">Jason D.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Himes</surname><given-names initials="BE">Blanca E.</given-names></name></contrib></contrib-group><pub-date pub-type="epub"><day>30</day><month>1</month><year>2024</year></pub-date><issue-id pub-id-type="pmc-issue-id">455764</issue-id><elocation-id>2024.01.29.24301962</elocation-id><pub-history><event event-type="pmc-release"><date><day>13</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>14</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-02 13:25:27.340"><day>02</day><month>12</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2024.01.29.24301962">http://medrxiv.org/lookup/doi/10.1101/2024.01.29.24301962</self-uri><self-uri content-type="pdf">nihpp-2024.01.29.24301962.pdf</self-uri><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="published-article" xml:lang="en" xlink:title="research-article" vol="4" elocation-id="100348" journal-id="J Allergy Clin Immunol Glob" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11585680"><article-title>Associations of aeroallergen testing with reduced oral corticosteroid bursts among adults with asthma</article-title><volume>4</volume><issue>1</issue><date><day>17</day><month>10</month><year>2024</year></date><elocation-id>100348</elocation-id><source>The Journal of Allergy and Clinical Immunology: Global</source><pub-id pub-id-type="doi">10.1016/j.jacig.2024.100348</pub-id><pub-id pub-id-type="pmcid">PMC11585680</pub-id><pub-id pub-id-type="pmid">39583037</pub-id></related-article><abstract><title>ABSTRACT</title><sec><title>BACKGROUND</title><p>Aeroallergen testing can improve precision care for persistent asthma and is recommended by the U.S. clinical guidelines. How testing benefits diverse populations of adults with asthma, and the importance of the testing modality used, are not fully understood.</p></sec><sec><title>OBJECTIVE</title><p>We sought to evaluate whether receipt of aeroallergen testing was associated with a reduction in oral corticosteroid (OCS) bursts.</p></sec><sec><title>METHODS</title><p>We used electronic health record data to conduct a retrospective, observational cohort study of adults with asthma who were prescribed an inhaled corticosteroid and had an Allergy/Immunology visit in a large health system between 1/1/2017-6/30/2022. Negative binomial regression models were used to evaluate whether OCS bursts in the 12-month period after an initial visit were reduced for patients who received aeroallergen testing. We also measured differences in benefit after excluding patients with chronic obstructive pulmonary disease (COPD) and smoking histories, and whether testing receipt was via skin prick or serum.</p></sec><sec><title>RESULTS</title><p>
668/1,383 (48.3%) patients received testing. Receipt of testing was not associated with fewer bursts in all patients (incidence rate ratio (IRR)=0.83 versus no testing, p=0.059), but it was among never smokers without COPD (417/844 tested, IRR=0.68, p=0.004). The receipt of
<italic toggle="yes">skin</italic>
testing was associated with fewer bursts in all patients (418/1,383 tested, IRR=0.77, p=0.02) and among never smokers without COPD (283/844 tested, IRR=0.59 versus no testing, p=0.001).
</p></sec><sec><title>CONCLUSION</title><p>Guideline-concordant aeroallergen testing in the context of Allergy/Immunology care was associated with clinical benefit in a real-life, diverse cohort of adults with asthma. This benefit varied according to patient comorbidities and the testing modality.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>